NXC-201 (formerly HBI0101) Multiple Myeloma
NXC-201 (formerly HBI0101) Multiple Myeloma
Active, not recruiting · NCT04720313 · Registry updated 2025-03-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NXC-201 (formerly HBI0101) Multiple Myeloma | Dose Escalation and Safety | Active, not recruiting | Phase 1 | 2025-03-14 | NCT04720313 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hadassah Medical Organization | 53 |
| Nexcella Inc. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hadassah University Hospital | Jerusalem | Israel | 1 |